Product Information
DEXTROAMPH-AMPHET ER 50 MG CAP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $7.7857 per EA under NDC 57664095388. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Sep 27, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMPH-AMPHET ER 50 MG CAP
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfateStrength
12.5; 12.5; 12.5; 12.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664095388
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215997FDA Approved
9/27/2023
TE Code
AB2
On Market Since
2/1/2024
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPH-AMPHET ER 50 MG CAP has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.7857 per EA |
|---|---|
| All-time high | $9.1313 (May 14, 2025) |
| All-time low | $7.7184 (Jul 17, 2024) |
| 52-week high | $8.5829 |
| 52-week low | $7.7857 |
| Median price | $8.4735 |
| Average price | $8.4164 |
| Largest weekly change | -10.8% (Jul 17, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMPH-AMPHET ER 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPH-AMPHET ER 50 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $7.7857 per EA (NDC 57664095388), effective Aug 19, 2026.
How has the price of DEXTROAMPH-AMPHET ER 50 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPH-AMPHET ER 50 MG CAP has declined 2.0%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DEXTROAMPH-AMPHET ER 50 MG CAP?
Since Apr 17, 2024, the NADAC for DEXTROAMPH-AMPHET ER 50 MG CAP has ranged from a low of $7.7184 (Jul 17, 2024) to a high of $9.1313 (May 14, 2025), with a median of $8.4735 per EA.
Are there cheaper alternatives to DEXTROAMPH-AMPHET ER 50 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPH-AMPHET ER 50 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPH-AMPHET ER 50 MG CAP?
DEXTROAMPH-AMPHET ER 50 MG CAP (NDC 57664095388) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.